CAH - Cardinal Health, Inc.

Price: -- -- | CONSENSUS: Buy DETAILS | PRICE TARGET: $253.38 DETAILS

Stock News

Zacks Industry Outlook McKesson, Cardinal, West Pharmaceutical, Align and Henry

McKesson, Cardinal, West Pharmaceutical, Align and Henry have been highlighted in this Industry Outlook article.

Jul 14, 2026 12:36 AM • zacks.com

Looking for a Growth Stock? 3 Reasons Why Cardinal (CAH) is a Solid Choice

Cardinal (CAH) is well positioned to outperform the market, as it exhibits above-average growth in financials.

Jul 13, 2026 09:46 AM • zacks.com

5 Medical Supply Stocks to Buy Amid Strong Industry Tailwinds

Here, we highlight five dental supplies stocks, MCK, CAH, WST, ALGN and HSIC, which are well positioned to generate wealth for investors amid improving industry prospect.

Jul 13, 2026 09:40 AM • zacks.com

Why Cardinal (CAH) is Poised to Beat Earnings Estimates Again

Cardinal (CAH) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Jul 13, 2026 09:10 AM • zacks.com

Here's Why Cardinal Health (CAH) is a Strong Growth Stock

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Jul 13, 2026 06:46 AM • zacks.com

These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar

Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.

Jul 13, 2026 05:56 AM • zacks.com

Wall Street Analysts See Cardinal (CAH) as a Buy: Should You Invest?

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.

Jul 10, 2026 06:30 AM • zacks.com

Should You Retain CAH Stock After Removal From Several Russell Indices?

CAH's Russell index removal reflects reclassification after its share rally, while specialty growth and resilient operations continue supporting its long-term outlook.

Jul 09, 2026 11:26 AM • zacks.com

Cardinal Health to Announce Fourth-Quarter and Year-End Results for Fiscal Year 2026 on August 11

DUBLIN, Ohio, July 9, 2026 /PRNewswire/ -- Cardinal Health (NYSE: CAH) plans to release fourth-quarter and year-end financial results for its fiscal year 2026 on August 11, prior to the opening of trading on the New York Stock Exchange. The company will webcast a discussion of these results beginning at 8:30 a.m.

Jul 09, 2026 02:45 AM • prnewswire.com

Cardinal Health (CAH) Declines More Than Market: Some Information for Investors

Cardinal Health (CAH) concluded the recent trading session at $237.15, signifying a -1.07% move from its prior day's close.

Jul 08, 2026 03:16 PM • zacks.com

Eli Lilly and vs. Teva: Which Pharmaceutical Stock Is a Better Buy in 2026?

Growth premium vs. value recovery, one trades at 33x forward earnings while the other navigates debt reduction and biosimilar expansion.

Jul 06, 2026 09:09 AM • fool.com

Cardinal Health: Why This Essential Healthcare Distributor Deserves A Buy Rating

Cardinal Health receives a Buy rating, supported by defensive business fundamentals, strong adjusted EPS growth, and strategic expansion into specialty healthcare. CAH's Q3FY26 showed 11% revenue growth and 35% adjusted EPS growth, though GAAP results were pressured by higher costs and special items. Valuation is at a premium with a Forward P/E of 21.64x, justified by improving profitability and cash flow, but future upside depends on sustained margin gains.

Jul 03, 2026 10:55 AM • seekingalpha.com

Why Cardinal Health (CAH) is a Top Value Stock for the Long-Term

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Jul 03, 2026 06:41 AM • zacks.com

Why Cardinal Health (CAH) is a Top Momentum Stock for the Long-Term

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Jul 02, 2026 06:51 AM • zacks.com

Are Investors Undervaluing Cardinal Health (CAH) Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Jul 01, 2026 06:41 AM • zacks.com